Full Name
Eng King Tan
Variants
Tan, E.-K.
Tan, E.K.
 
 
 
Email
gmstek@nus.edu.sg
 

Refined By:
Type:  Others

Results 1-16 of 16 (Search time: 0.005 seconds).

Issue DateTitleAuthor(s)
1Mar-2012Camptocormia in Parkinson's disease: Dystonia or myopathy?Peeraully, T.; Tan, E.-K. 
22014Consensus-based clinical practice recommendations for the examination and management of falls in patients with Parkinson's diseasevan der Marck M.A.; Klok M.P.; Okun M.S.; Giladi N.; Munneke M.; Bloem B.R.; Arney K.; Browner N.M.; Caunter M.; Cianci H.J.; Dunlop B.; Eggert K.; Fisher B.; Hass C.J.; Hunter C.; Jabre M.; Kraakevik J.; Lyons K.E.; Phibbs F.; Scott B.L.; Shih L.; Tan E.-K. ; Tan L.; Varanese S.; Voss T.; Ashburn A.; Ballinger C.; Bhatti M.T.; Hausdorff J.; Lindvall S.; Morris M.E.; Nieuwboer A.; Schwalb J.M.; Studenski S.; Wood B.H.
32020Corrigendum: Gut–Brain Axis: Potential Factors Involved in the Pathogenesis of Parkinson's Disease (Front. Neurol., (2020), 11, (849), 10.3389/fneur.2020.00849)Chao, Y.-X.; Gulam, M.Y.; Chia, N.S.J.; Feng, L. ; Rotzschke, O.; Tan, E.-K. 
42017Erratum to: Mitochondrial CHCHD-Containing Proteins: Physiologic Functions and Link with Neurodegenerative Diseases (Molecular Neurobiology, (2017), 54, 7, (5534-5546), 10.1007/s12035-016-0099-5)Zhou Z.-D. ; Saw W.-T.; Tan E.-K. 
52018Erratum to: Superoxide drives progression of Parkin/PINK1-dependent mitophagy following translocation of Parkin to mitochondria (Cell Death and Disease, (2017), 8, 10, (e3097), 10.1038/cddis.2017.463)Xiao B.; Deng X.; Lim G.G.; Xie S. ; Zhou Z.D.; Lim K.-L. ; Tan E.-K. 
62010Erratum: Analysis of GWAS-linked loci in Parkinson Disease reaffirms PARK16 as a susceptibility locus (Neurology (2010) 75 (508-512))Tan E.-K. 
7May-2013Headache in hemifacial spasm patientsPeeraully, T.; Tan, S.-F.; Fook-Chong, S.M.C.; Prakash, K.M.; Tan, E.-K. 
82014Identification of a novel risk variant in the FUS gene in essential tremor Author responseTan E.-K. ; Wu Y.-R.
92018Identifying genes in parkinson disease: State of the artChew E.G.Y.; Foo J.N.; Tan E.-K. 
10Oct-2008Lrrk2 R1628P in non-Chinese Asian racesTan, E.-K. ; Tang, M.; Tan, L.C.; Wu, Y.-R.; Wu, R.-M.; Ross, O.A.; Zhao, Y.
11Jul-2008Molecular biology changes associated with LRRK2 mutations in Parkinson's diseaseYi, W.L.; Tan, E.-K. 
122010PLA2G6 mutations and Parkinson's diseaseTan, E.K. ; Ho, P.; Tan, L.; Prakash, K.M.; Zhao, Y.
13Oct-2011Rare and common LRRK2 exonic variants in Parkinson's diseaseTan, E.-K. 
142018Towards better cellular replacement therapies in Parkinson diseaseSun A.X. ; Tan E.-K. 
152008Uniting Chinese across Asia: The LRRK2 Gly2385Arg risk variant (European Journal of Neurology (2008) 15, (203-204))Tan E.K. ; Schapira A.H.
162009Utility of lymphoblastoid cell linesSie, L.; Loong, S.; Tan, E.-K.